SAB Biotherapeutics
SABS
SABS
38 hedge funds and large institutions have $2.42M invested in SAB Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 40 → 38 (-2)
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$423K | |
| 2 | +$339K | |
| 3 | +$69.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$63.1K |
| 5 |
SOS
Silver Oak Securities
Jackson,
Tennessee
|
+$47.5K |
Top Sellers
| 1 | -$105K | |
| 2 | -$35.1K | |
| 3 | -$27K | |
| 4 |
Jane Street
New York
|
-$17K |
| 5 |
BlackRock
New York
|
-$16.1K |